drugset / Trial / NCT03860532

Phase I Clinical Trial in Healthy Male Volunteers

NCT03860532 ↗

Phase 1 Completed 24 enrolled Hutchison Medipharma Limited
RandomizedCrossoverDouble-blindDiagnostic

Summary

This is a Phase I Randomized,Double-Blind,Placebo-controlled Trial in Healthy Male Voluteers To Examine the Safety,Tolerability,and Pharmacokinetics of HMPL-011 After A Single Dose.

Timeline

Start
2011-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator HMPL-011 Unknown 800 mg Oral
Comparator HMPL-011 Unknown 1200 mg Oral